TB Notes Newsletter
Return to TB Notes 1,
2006 Main Menu
This is an archived document. The links
and content are no longer being updated.
No. 1, 2006
NEW CDC PUBLICATIONS
CDC. Controlling tuberculosis in the United States: recommendations
from the American Thoracic Society, CDC, and the Infectious Diseases
Society of America. MMWR 2005; 54 (RR-12): 1-81.
CDC. Guidelines for preventing the transmission of Mycobacterium
tuberculosis in health-care settings, 2005. MMWR 2005; 54 (RR-17):
1-141.
CDC. Guidelines for the investigation of contacts of persons with
infectious tuberculosis: recommendations from the National Tuberculosis
Controllers Association and CDC. MMWR 2005; 54 (RR-15):
1-37.
CDC. Guidelines for using the QuantiFERON-TB Gold Test for detecting
Mycobacterium tuberculosis infection, United States. MMWR
2005; 54 (RR-15): 49-55.
CDC. Mycobacterium tuberculosis transmission in a newborn nursery
and maternity ward—New York City, 2003. MMWR 2005;
54 (50): 1280-1283.
Clark CM, Li J, Driver CR, and Munsiff SS. Risk factors for drug-resistant
tuberculosis among non-US-born persons in New York City. International
Journal of Tuberculosis and Lung Disease 2005; 9(9): 964-9.
Fujiwara PI, Clevenbergh P, and Dlodlo RA. Management of adults
living with HIV/AIDS in low-income, high-burden settings, with special
reference to persons with tuberculosis. International Journal of
Tuberculosis and Lung Disease 2005; 9(9): 946-58.
Ijaz K, Jereb J, Lambert L, Bower W, Spradling P, McElroy P, Iademarco
M, Navin T, and Castro K. Severe or fatal liver injury in 50 patients
in the United States taking rifampin and pyrazinamide for latent
tuberculosis infection. Clinical Infectious Diseases 2006;
42: 346-355.
Lee LM, Lobato MN, Buskin SE, Morse A, Costa S. Low adherence
to guidelines for preventing TB among persons with newly diagnosed
HIV infection, United States. International Journal of Tuberculosis
and Lung Disease 2006; 10(2): 209-214.
Maloney SA, Fielding KL, Laserson KF, et al. Assessing the performance
of overseas tuberculosis screening programs: a study among US-bound
immigrants in Vietnam. Arch Intern Med 2006; (2)166: 234-240.
Miller TL, Hilsenrath P, Lykens K, McNabb SJ, Moonan PK, Weis
SE. Using cost and health impacts to prioritize the targeted testing
of tuberculosis in the United States. Annals of Epidemiology
2005 Oct. 20 [Epub ahead of print].
Nelson LJ, Naik Y, Tsering K and Cegielski JP. Population-based
risk factors for tuberculosis and adverse outcomes among Tibetan
refugees in India, 1994-1996. International Journal of Tuberculosis
and Lung Disease 2005; 9 (9): 1018-26.
Shah NS, Harrington T, Huber M, Wellnitz C, Fridrych S, Laserson
K, Gonzalez IM, and Ijaz K. Increased reported cases of tuberculosis
among children younger than 5 years of age, Maricopa County, Arizona,
2002-2003. The Pediatric Infectious Diseases Journal 2006;
25: 151-155.
Weiner M, Benator D, Peloquin CA, Burman W, Vernon A, Engle M,
Khan A, and Zhao Z. Evaluation of the drug interaction between rifabutin
and efavirenz in patients with HIV infection and tuberculosis. Clinical
Infectious Diseases 2005; 41(9): 1343-9.
White MC, Tulsky JP, Menendez E, Goldenson J, and Kawamura LM.
Incidence of TB in inmates with latent TB infection: 5-year follow-up.
American Journal of Preventive Medicine 2005; 29(4): 295-301.
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|